Gizem Gürbostan Soysal, Sevim Ayca Seyyar, Murat Mercanlı, Yara Chiekhismailzadeh, Burçak Balyemez, Kübra Çetinkaya, Sabit Kimyon
{"title":"Evaluation of the effects of different mydriatic drops used on choroidal vascularity in healthy children.","authors":"Gizem Gürbostan Soysal, Sevim Ayca Seyyar, Murat Mercanlı, Yara Chiekhismailzadeh, Burçak Balyemez, Kübra Çetinkaya, Sabit Kimyon","doi":"10.1097/IAE.0000000000004380","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the effects of mydriatics drops used primarily in routine eye examinations on the choroid tissue, which has a dense vascular network in the eye.</p><p><strong>Methods: </strong>This prospective observational study included 90 eyes of 90 healthy children. Optical coherence tomography (OCT) images were obtained for all children before dilation. They were randomly divided into two groups (46/44). The tropicamide group received 0.5% tropicamide and the phenylephrine group received 2.5% phenylephrine. After dilation, a second OCT image was obtained for all children.</p><p><strong>Results: </strong>Subfoveal choroidal thickness (SCFT) values decreased significantly after dilation in the phenylephrine and tropicamide drop groups compared to pre-dilation measurements (p=0.001 for both). No significant difference was observed in the choroidal vascularity index (CVI) values measured before and after dilation in either group (p=0.059, p=0.245).</p><p><strong>Conclusion: </strong>While 2.5% phenylephrine and 0.5% tropicamide caused a decrease in SCFT values after dilatation, there was no significant difference in CVI values. These results emphasize that when examining choroidal thickness and vascularity in individuals with chorioretinal disease, the selection of mydriatic agent should be taken into consideration, especially in choroidal thickness.</p>","PeriodicalId":54486,"journal":{"name":"Retina-The Journal of Retinal and Vitreous Diseases","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Retina-The Journal of Retinal and Vitreous Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/IAE.0000000000004380","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose: To evaluate the effects of mydriatics drops used primarily in routine eye examinations on the choroid tissue, which has a dense vascular network in the eye.
Methods: This prospective observational study included 90 eyes of 90 healthy children. Optical coherence tomography (OCT) images were obtained for all children before dilation. They were randomly divided into two groups (46/44). The tropicamide group received 0.5% tropicamide and the phenylephrine group received 2.5% phenylephrine. After dilation, a second OCT image was obtained for all children.
Results: Subfoveal choroidal thickness (SCFT) values decreased significantly after dilation in the phenylephrine and tropicamide drop groups compared to pre-dilation measurements (p=0.001 for both). No significant difference was observed in the choroidal vascularity index (CVI) values measured before and after dilation in either group (p=0.059, p=0.245).
Conclusion: While 2.5% phenylephrine and 0.5% tropicamide caused a decrease in SCFT values after dilatation, there was no significant difference in CVI values. These results emphasize that when examining choroidal thickness and vascularity in individuals with chorioretinal disease, the selection of mydriatic agent should be taken into consideration, especially in choroidal thickness.
期刊介绍:
RETINA® focuses exclusively on the growing specialty of vitreoretinal disorders. The Journal provides current information on diagnostic and therapeutic techniques. Its highly specialized and informative, peer-reviewed articles are easily applicable to clinical practice.
In addition to regular reports from clinical and basic science investigators, RETINA® publishes special features including periodic review articles on pertinent topics, special articles dealing with surgical and other therapeutic techniques, and abstract cards. Issues are abundantly illustrated in vivid full color.
Published 12 times per year, RETINA® is truly a “must have” publication for anyone connected to this field.